Clinical trials
Suspended Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| AstraZeneca | 1 |
| CHU de Quebec-Universite Laval | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| City of Hope Medical Center | 1 |
| Columbia University | 1 |
| Emory University | 1 |
| Envita Medical Center, Inc. | 1 |
| Enzon Pharmaceuticals, Inc. | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 33 |
| Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Renal Cell | 2 |
| Carcinoma, Transitional Cell | 2 |
| Colonic Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
Trials
Showing 26 to 33 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.